CD19 and rheumatoid arthritis: Studies have found increased miR-155-5p expression in blood-derived CD19+ B-cells in newly diagnosed RA patients and decreased production of CD27+IgD+ B-cells and the IgM antibodies they produce in peripheral blood of RA patients, suggesting a unique BCR repertoire [51,52].